Oxycodone Hcl
FDA recalls
5 rows
| Date | Company and reason |
|---|---|
| Jan 13, 2026 | Amerisource Health Services LLC Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities. |
| Oct 19, 2023 | Zyla Life Sciences US Inc. Sub-potent Drug: Lower potency than labeled. |
| Dec 28, 2021 | Lupin Pharmaceuticals Inc. Out-of-specification impurity test result observed at 18-month long term stability time point. |
| Aug 18, 2021 | Rhodes Pharmaceuticals, L.P. Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle |
| Jan 21, 2018 | Ascent Pharmaceuticals, Inc. Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol |
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).